Inventor · disambiguated record
Andrea Biffi
Also filed as: BIFFI ANDREA
16 granted patents·29 pending applications·13 citations·filing 2014–2023
87Inventor score
Top patents by PatentIndex Score
45 records- 0192US11400124B2Use of probiotics for improving protein absorptionSOFAR SPA·Filed 2017·Granted Aug 2, 2022·5 cites·9 claims
- 0283US11464814B2Topical composition for use in the treatment of inflammatory bowel diseaseSOFAR SPA·Filed 2015·Granted Oct 11, 2022·5 cites·26 claims
- 0381US11591416B2Exopolysaccharides and uses thereofSOFAR SPA·Filed 2017·Granted Feb 28, 2023·3 cites·12 claims
- 0472US11534468B2Composition based on probiotics and uses thereofLAC2BIOME S R L·Filed 2018·Granted Dec 27, 2022·0 cites·5 claims
- 0570US2024050497A1Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acidALFASIGMA SPA·Filed 2023·Application pending·0 cites
- 0668US2023052820A1Topical composition for use in the treatment of inflammatory bowel diseaseSOFAR SPA·Filed 2022·Application pending·0 cites
- 0766US2023093060A1Composition based on probiotics and uses thereofLAC2BIOME S R L·Filed 2022·Application pending·0 cites
- 0864US11839634B2Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acidALFASIGMA SPA·Filed 2014·Granted Dec 12, 2023·0 cites·10 claims
- 0964US11690867B2Liquid composition for use in the treatment of gastroesophageal refluxSOFAR SWISS SA·Filed 2022·Granted Jul 4, 2023·0 cites·20 claims
- 1061US11690889B2Composition for use in the treatment of intestinal alterationsSOFAR SPA·Filed 2020·Granted Jul 4, 2023·0 cites·11 claims
- 1161US2025009818A1Bacteria strains for topical skin careLAC2BIOME S R L·Filed 2022·Application pending·0 cites
- 1261US2020337996A1Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereofSOFAR SWISS SA·Filed 2018·Application pending·0 cites
- 1360US11751597B2Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systemsALFASIGMA SPA·Filed 2020·Granted Sep 12, 2023·0 cites·13 claims
- 1460US2023330164A1Composition comprising lactoferrin and probiotic bacterial strains for oral use with antiviral actionSOFAR SPA·Filed 2021·Application pending·0 cites
- 1560US2019125664A1Tablet to be sucked and/or dissolved in the mouth based on hyaluronic acid and chondroitin sulphate and their saltsSOFAR SWISS SA·Filed 2018·Application pending·0 cites
- 1659US10881703B2Composition for use in the treatment of intestinal alterationsSOFAR SPA·Filed 2017·Granted Jan 5, 2021·0 cites·11 claims
- 1758US2025325606A1Lacticaseibacillus paracasei dg(r) cncm i-1572 dsm 34154 for use in a method of treating dysbiosis in patients with ibsALFASIGMA SPA·Filed 2023·Application pending·0 cites
- 1858US2022218776A1Composition for use in a method for prevention or treatment of maltnutrition in a subject suffering from a chronic inflammatory bowel diseasesSOFAR SPA·Filed 2020·Application pending·0 cites
- 1958US2023080695A1Lactoferrin for oral use with antiviral actionSOFAR SPA·Filed 2020·Application pending·0 cites
- 2058US2024350567A1Use of lactobacillus paracasei bacterial strains in the treatment of newbornsALFASIGMA SPA·Filed 2022·Application pending·0 cites
- 2157US2024148804A1Inactivated strains of bacteria, such as viable but non-culturable bacteria, compositions and use thereofBLL INVEST S R L·Filed 2022·Application pending·0 cites
- 2256US2020337995A1Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof for use in the treatment of a subpopulation of gerd patientsSOFAR SWISS SA·Filed 2018·Application pending·0 cites
- 2355US12036254B2Bacterial strains of the Lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tractLAC2BIOME S R L·Filed 2019·Granted Jul 16, 2024·0 cites·14 claims
- 2455US2019125665A1Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof for use in the treatment of subpopulation of GERD patientsSOFAR SWISS SA·Filed 2018·Application pending·0 cites
- 2554US11337992B2Liquid composition for use in the treatment of gastroesophageal refluxSOFAR SWISS SA·Filed 2017·Granted May 24, 2022·0 cites·3 claims
- 2653US12472214B2Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin D deficiency, and disorders associated therewithALFASIGMA SPA·Filed 2021·Granted Nov 18, 2025·0 cites·6 claims
- 2753US2023355659A1Compositions comprising a vegetable chondroitin or an analogue thereof and the use thereof in the treatment of disorders of the mucous membrane of the oral, pharyngo-laryngeal and/or gastro-oesophageal tractSOFAR SWISS SA·Filed 2021·Application pending·0 cites
- 2853US2023355692A1Compositions comprising a vegetable chondroitin or an analogue thereof and the use thereof in the treatment of disorders of the mucous membrane of the oral, pharyngo-laryngeal and/or gastro-oesophageal tractSOFAR SWISS SA·Filed 2021·Application pending·0 cites
- 2952US12447183B2Bacterial strains, their compositions and their use for the treatment of gastrointestinal disordersALFASIGMA SPA·Filed 2020·Granted Oct 21, 2025·0 cites·5 claims
- 3052US11752179B2Medical use of probioticsALFASIGMA SPA·Filed 2017·Granted Sep 12, 2023·0 cites·16 claims
- 3152US2023098743A1Bacterial strains and compositions thereof for oral use in the treatment of viral infections of the respiratory systemSOFAR SPA·Filed 2021·Application pending·0 cites
- 3250US2022370520A1Compositions based on bacterial strains and berry extracts and their use as anti-inflammatoriesSOFAR SPA·Filed 2020·Application pending·0 cites
- 3350US2022325234A1Bacterial strains, their compositions and their use for the treatment of gastrointestinal disordersSOFAR SPA·Filed 2020·Application pending·0 cites
- 3450US2016348155A1Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiotaSOFAR SPA·Filed 2014·Application pending·0 cites
- 3549US2022409676A1Compositions comprising bacterial strains for use in increasng the bioavailability of amino acids derived from proteinsSOFAR SPA·Filed 2020·Application pending·0 cites
- 3648US11338002B2Use for treatment of clostridium difficile infectionsLAC2BIOME S R L·Filed 2018·Granted May 24, 2022·0 cites·16 claims
- 3748US2022313753A1Bifidobacterium bifidum bacterial strain, the compositions thereof and related usesSOFAR SPA·Filed 2020·Application pending·0 cites
- 3848US2022354910A1Compositions based on bacterial strains and their use as anti-inflammatoriesSOFAR SPA·Filed 2020·Application pending·0 cites
- 3947US2020405745A1Liquid composition for use in the treatment of the mucosa of the oro-pharyngo-laryngo-esophageal tractSOFAR SWISS SA·Filed 2019·Application pending·0 cites
- 4045US11896631B2Probiotics for use in the treatment of diverticulosis and diverticular diseaseALFASIGMA SPA·Filed 2017·Granted Feb 13, 2024·0 cites·20 claims
- 4145US2021315810A1Composition containing a mucolytic agent for the treatment of mucus hypersecretion and a device for the dosing thereofSOFAR SPA·Filed 2019·Application pending·0 cites
- 4245US2022313757A1Compositions comprising a bacterial strain lactobacillus paracasei and hyaluronic acid and the use thereof for the treatment of the skinLAC2BIOME S R L·Filed 2020·Application pending·0 cites
- 4344US2021268004A1Composition containing beclomethasone for the prevention and the treatment of bacterial prostatitis and vaginitisSOFAR SPA·Filed 2019·Application pending·0 cites
- 4442US2021222130A1Model for in-vitro simulation of the behaviour of dysfunctional vessels1LAB SA·Filed 2019·Application pending·0 cites
- 4540US2022098549A1Method for characterising a tissue-engineered construct1LAB SA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrea Biffi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →